US Patent Issued to Anavex Life Sciences on Sept. 15 for "Neurodevelopmental disorder therapy" (New York Inventor)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,147, issued on Sept. 15, was assigned to Anavex Life Sciences Corp. (New York).

"Neurodevelopmental disorder therapy" was invented by Christopher U. Missling (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention addresses tetrahydro-N, N-dimethyl-2,2diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73, AV2-73, or A2-73) in a method of treatment for neurodevelopmental disorders. Particular reference is made to the treatment of autism spectrum disorder, cerebral palsy, Rett syndrome, Angelman syndrome, Williams syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS), childhood disintegrative disorder, and Smith...